MD Anderson Research Highlights for March 9, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic,...
MD Anderson Research Highlights for February 23, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic,...
MD Anderson receives over $31 million in CPRIT funding
The University of Texas MD Anderson Cancer Center was awarded $31.73 million from the Cancer Prevention and Research Institute of...
MD Anderson Research Highlights for February 9, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic,...
MD Anderson honors World Cancer Day, reinforces commitment...
The University of Texas MD Anderson Cancer Center celebrates World Cancer Day, Feb. 4, in honor of the global initiative to end cancer.
MD Anderson Research Highlights for January 26, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic,...
MD Anderson researchers elected as AAAS Fellows
In honor of their notable contributions to the field of cancer research, Juan Fueyo, M.D., and Victor Prieto, M.D., Ph.D., from The...
MD Anderson Research Highlights for January 12, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic,...
MD Anderson Research Highlights for December 15, 2021
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic,...
Venetoclax combination therapies found effective against...
ABSTRACTS 691, 371, 794
Combination therapies including venetoclax and another therapy have displayed promising results against...